Skip to main content
Figure 4 | Cancer Cell International

Figure 4

From: Targeting PI3K/Akt represses Hypoxia inducible factor-1α activation and sensitizes Rhabdomyosarcoma and Ewing’s sarcoma cells for apoptosis

Figure 4

Sensitization of A204 and A673 cells for doxorubicin- and TRAIL- induced apoptosis is caspase dependent. A204 (A) and A673 (B) cells were pretreated with 0 or 30 μmol/L of LY294002 for 1 hour, and cultured under normoxic or hypoxic conditions with doxorubicin (0.5 μg/ml) or TRAIL (100 ng/ml) for up to 72 hours with or without or z-VAD-fmk (50 μmol/L) 24 hours-white bars, 48 hours-black bars, 72 hours-hatched bars Columns, mean of three independent experiments done in duplicate; bars, SD. For statistical analysis two-way ANOVA was performed comparing specific apoptosis of either LY294002 + TRAIL or doxorubicin--induced apoptosis without z-VAD-fmk vs with z-VAD-fmk under normoxia (*p < 0.05, **p < 0.01) or the same comparison of specific apoptosis under hypoxia (#p < 0.05, ##p < 0.01).

Back to article page